About PathologyWatch
PathologyWatch is a company based in Salt Lake City (United States) founded in 2018 by Dan Lambert, Michael Torno, and Gregory Osmond was acquired by Sonic Healthcare in November 2023.. PathologyWatch has raised $34.34 million across 4 funding rounds from investors including Sonic Healthcare, Ceros Capital Markets and Rock Creek Capital. PathologyWatch offers products and services including Digital Slides Access and EMR Integration. PathologyWatch operates in a competitive market with competitors including Skin Analytics, Haut, 3Derm, Nia Health and Love My Delta, among others.
- Headquarter Salt Lake City, United States
- Founders Dan Lambert, Michael Torno, Gregory Osmond
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$34.34 M (USD)
in 4 rounds
-
Latest Funding Round
$25 M (USD), Series B
Nov 16, 2021
-
Investors
Sonic Healthcare
& 13 more
-
Employee Count
Employee Count
-
Acquired by
Sonic Healthcare
(Nov 16, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PathologyWatch
PathologyWatch offers a comprehensive portfolio of products and services, including Digital Slides Access and EMR Integration. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides 24/7 access to digital pathology slides for review
Automates report integration into electronic medical records for efficiency
Unlock access to complete
Unlock access to complete
Funding Insights of PathologyWatch
PathologyWatch has successfully raised a total of $34.34M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $25 million completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $25.0M
-
First Round
First Round
(07 May 2019)
- Investors Count 13
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2021 | Amount | Series B - PathologyWatch | Valuation | Ceros Capital Markets , Spark Growth Ventures | |
| Dec, 2020 | Amount | Series A - PathologyWatch | Valuation | Neue Fund , Bioventure | |
| May, 2020 | Amount | Series A - PathologyWatch | Valuation | Rock Creek Capital , SpringTide |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in PathologyWatch
PathologyWatch has secured backing from 14 investors, including venture fund and institutional investors. Prominent investors backing the company include Sonic Healthcare, Ceros Capital Markets and Rock Creek Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are focused on tech startups.
|
Founded Year | Domain | Location | |
|
Private equity and venture investments are provided to build businesses.
|
Founded Year | Domain | Location | |
|
Early-stage tech startups are invested in by Spark Growth Ventures.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by PathologyWatch
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - PathologyWatch
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Pathologywatch Comparisons
Competitors of PathologyWatch
PathologyWatch operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Skin Analytics, Haut, 3Derm, Nia Health and Love My Delta, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of smartphone based skin cancer detection
|
|
| domain | founded_year | HQ Location |
SaaS solutions using AI for skincare businesses are provided.
|
|
| domain | founded_year | HQ Location |
Skin images are analyzed digitally for disease detection by dermatologists.
|
|
| domain | founded_year | HQ Location |
Digital therapeutics are provided for personalized dermatology and allergology support.
|
|
| domain | founded_year | HQ Location |
AI-based skin analysis tool for wellness, beauty, and aesthetic medicine
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Pathologywatch
Frequently Asked Questions about PathologyWatch
When was PathologyWatch founded?
PathologyWatch was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Where is PathologyWatch located?
PathologyWatch is headquartered in Salt Lake City, United States. It is registered at Salt Lake City, Utah, United States.
Who is the current CEO of PathologyWatch?
Dan Lambert is the current CEO of PathologyWatch. They have also founded this company.
Is PathologyWatch a funded company?
PathologyWatch is a funded company, having raised a total of $34.34M across 4 funding rounds to date. The company's 1st funding round was a Series A of $5M, raised on May 07, 2019.
What does PathologyWatch do?
PathologyWatch offers clinical workflow management and decision-making software and services for professionals. The software platform enables the pathologist to upload a digital sample of slides in the cloud and automate the result to their EHR system for hospital operations. The company provides services for digital pathology, dermatopathology where samples can be sent to the company for biopsy and interpretation. Products like PathologyWatch, ValueWatch, and Business watch assist with the laboratory functions and operations like remote image viewing, Electronic Medical Records integration, and more.
Who are the top competitors of PathologyWatch?
PathologyWatch's top competitors include Skin Analytics, 3Derm and Haut.
What products or services does PathologyWatch offer?
PathologyWatch offers Digital Slides Access and EMR Integration.
Who are PathologyWatch's investors?
PathologyWatch has 14 investors. Key investors include Sonic Healthcare, Ceros Capital Markets, Rock Creek Capital, Spark Growth Ventures, and Blueprint Health.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.